脂肪组织纤维化生成增加而非扩展性受损与非酒精性脂肪性肝病相关
研究比较了健康瘦者、肥胖但肝内甘油三酯正常者及肥胖伴NAFLD和糖代谢异常者的腹部皮下脂肪组织脂肪生成与纤维化生成。结果显示肥胖者皮下脂肪甘油三酯合成率均高于瘦者,但肥胖伴NAFLD者与肥胖但肝内甘油三酯正常者无差异;而皮下脂肪胶原合成率及胶原基因表达从瘦者到肥胖正常者再到肥胖NAFLD者逐步增加,且胶原基因表达与肝脏及全身胰岛素敏感性呈负相关。结论认为肥胖伴NAFLD者脂肪组织扩展性并未受损,但皮下脂肪纤维化生成增加并与胰岛素抵抗相关。
要点
- 肥胖者皮下脂肪甘油三酯合成率高于瘦者,但伴或不伴NAFLD的肥胖者间无差异。
- 皮下脂肪胶原合成率及胶原基因表达在肥胖伴NAFLD者中最高,且与胰岛素敏感性负相关。
- 脂肪组织扩展性受损并非肥胖伴NAFLD的特征,纤维化生成增加才是相关因素。
核心结论
- 肥胖伴NAFLD者脂肪组织扩展性未受损,但皮下脂肪纤维化生成增加并与肝脏及全身胰岛素敏感性负相关。
研究设计与样本
- 研究纳入三组参与者:健康瘦者肝内甘油三酯正常组(Lean-NL,n=12)、肥胖肝内甘油三酯正常且糖耐量正常组(Ob-NL,n=25)、肥胖伴NAFLD及糖代谢异常组(Ob-NAFLD,n=25)。
- 评估了体内腹部皮下脂肪组织脂肪生成和纤维化生成、细胞外基质形成相关基因表达及胰岛素敏感性。
主要发现
- 腹部皮下脂肪甘油三酯合成率在Ob-NL组为65.9 ± 4.6 g/wk,Ob-NAFLD组为71.1 ± 6.7 g/wk,均高于Lean-NL组的16.2 ± 2.8 g/wk(P < 0.05),但Ob-NL与Ob-NAFLD组间无差异。
- 腹部皮下脂肪胶原合成率及编码胶原的基因复合表达从Lean-NL到Ob-NL再到Ob-NAFLD组逐步增加,且Ob-NAFLD组高于Ob-NL组(P < 0.05)。
- 胶原基因复合表达与肝脏及全身胰岛素敏感性呈负相关(P < 0.001)。
临床怎么用
- 在肥胖伴NAFLD患者中,应关注皮下脂肪纤维化生成增加而非扩展性受损,其与胰岛素抵抗相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: It is proposed that impaired expansion of subcutaneous adipose tissue (SAT) and an increase in adipose tissue (AT) fibrosis causes ectopic lipid accumulation, insulin resistance (IR), and metabolically unhealthy obesity. We therefore evaluated whether a decrease in SAT expandability, assessed by measuring SAT lipogenesis (triglyceride [TG] production), and an increase in SAT fibrogenesis (collagen production) are associated with NAFLD and IR in persons with obesity. APPROACH AND RESULTS: In vivo abdominal SAT lipogenesis and fibrogenesis, expression of SAT genes involved in extracellular matrix (ECM) formation, and insulin sensitivity were assessed in three groups of participants stratified by adiposity and intrahepatic TG (IHTG) content: (1) healthy lean with normal IHTG content (Lean-NL; n = 12); (2) obese with normal IHTG content and normal glucose tolerance (Ob-NL; n = 25); and (3) obese with NAFLD and abnormal glucose metabolism (Ob-NAFLD; n = 25). Abdominal SAT TG synthesis rates were greater (P < 0.05) in both the Ob-NL (65.9 ± 4.6 g/wk) and Ob-NAFLD groups (71.1 ± 6.7 g/wk) than the Lean-NL group (16.2 ± 2.8 g/wk) without a difference between the Ob-NL and Ob-NAFLD groups. Abdominal SAT collagen synthesis rate and the composite expression of genes encoding collagens progressively increased from the Lean-NL to the Ob-NL to the Ob-NAFLD groups and were greater in the Ob-NAFLD than the Ob-NL group (P < 0.05). Composite expression of collagen genes was inversely correlated with both hepatic and whole-body insulin sensitivity (P < 0.001). CONCLUSIONS: AT expandability is not impaired in persons with obesity and NAFLD. However, SAT fibrogenesis is greater in persons with obesity and NAFLD than in those with obesity and normal IHTG content, and is inversely correlated with both hepatic and whole-body insulin sensitivity.
引用
- Beals JW, Smith GI, Shankaran M, et al. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease. Hepatology. 2021. PMID: 33743554. doi:10.1002/hep.31822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。